Cargando…
Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction
Bovine whey IgG enriched fraction contains antibodies against various human bacterial pathogens. It contains antibodies against some viral antigens, including human respiratory syncytial virus and influenza virus. We investigated whether the IgG enriched fraction has cross-reactivity with IgG antibo...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier Ltd.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840401/ https://www.ncbi.nlm.nih.gov/pubmed/33526960 http://dx.doi.org/10.1016/j.idairyj.2021.105002 |
_version_ | 1783643568260251648 |
---|---|
author | Oshiro, Satoshi Tada, Tatsuya Mizutani, Naeko Funatogawa, Keiji Sekiguchi, Jun-ichiro Takahashi, Masao Kirikae, Teruo |
author_facet | Oshiro, Satoshi Tada, Tatsuya Mizutani, Naeko Funatogawa, Keiji Sekiguchi, Jun-ichiro Takahashi, Masao Kirikae, Teruo |
author_sort | Oshiro, Satoshi |
collection | PubMed |
description | Bovine whey IgG enriched fraction contains antibodies against various human bacterial pathogens. It contains antibodies against some viral antigens, including human respiratory syncytial virus and influenza virus. We investigated whether the IgG enriched fraction has cross-reactivity with IgG antibodies against SARS-CoV-2 spike (S) and nucleocapsid (N) proteins. The full-length and partial-length SARS-CoV-2 S, N, a recombinant protein of the receptor binding domain (RBD) and nine peptides covering the receptor binding motif (RBM) of S were prepared. Direct enzyme-linked immunosorbent assays were conducted using these recombinant proteins and peptides as coating antigens and revealed the IgG enriched fraction contained antibodies against partial-length S [amino acids (aa) 177–512, 288–512, 348–578, 387–516 and 408–664], full-length N (aa 1–419) and partial-length N (aa 1–120, 111–220, 1–220 and 210–419), two RBD peptides, covering aa 427–446 and 502–520 of S, and recombinant RBD of S. These results indicate IgG enriched fraction contains antibodies against SARS-CoV-2. |
format | Online Article Text |
id | pubmed-7840401 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | Elsevier Ltd. |
record_format | MEDLINE/PubMed |
spelling | pubmed-78404012021-01-28 Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction Oshiro, Satoshi Tada, Tatsuya Mizutani, Naeko Funatogawa, Keiji Sekiguchi, Jun-ichiro Takahashi, Masao Kirikae, Teruo Int Dairy J Short Communication Bovine whey IgG enriched fraction contains antibodies against various human bacterial pathogens. It contains antibodies against some viral antigens, including human respiratory syncytial virus and influenza virus. We investigated whether the IgG enriched fraction has cross-reactivity with IgG antibodies against SARS-CoV-2 spike (S) and nucleocapsid (N) proteins. The full-length and partial-length SARS-CoV-2 S, N, a recombinant protein of the receptor binding domain (RBD) and nine peptides covering the receptor binding motif (RBM) of S were prepared. Direct enzyme-linked immunosorbent assays were conducted using these recombinant proteins and peptides as coating antigens and revealed the IgG enriched fraction contained antibodies against partial-length S [amino acids (aa) 177–512, 288–512, 348–578, 387–516 and 408–664], full-length N (aa 1–419) and partial-length N (aa 1–120, 111–220, 1–220 and 210–419), two RBD peptides, covering aa 427–446 and 502–520 of S, and recombinant RBD of S. These results indicate IgG enriched fraction contains antibodies against SARS-CoV-2. Elsevier Ltd. 2021-06 2021-01-28 /pmc/articles/PMC7840401/ /pubmed/33526960 http://dx.doi.org/10.1016/j.idairyj.2021.105002 Text en © 2021 Elsevier Ltd. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active. |
spellingShingle | Short Communication Oshiro, Satoshi Tada, Tatsuya Mizutani, Naeko Funatogawa, Keiji Sekiguchi, Jun-ichiro Takahashi, Masao Kirikae, Teruo Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction |
title | Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction |
title_full | Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction |
title_fullStr | Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction |
title_full_unstemmed | Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction |
title_short | Presence of antibodies against SARS-CoV-2 spike protein in bovine whey IgG enriched fraction |
title_sort | presence of antibodies against sars-cov-2 spike protein in bovine whey igg enriched fraction |
topic | Short Communication |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7840401/ https://www.ncbi.nlm.nih.gov/pubmed/33526960 http://dx.doi.org/10.1016/j.idairyj.2021.105002 |
work_keys_str_mv | AT oshirosatoshi presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction AT tadatatsuya presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction AT mizutaninaeko presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction AT funatogawakeiji presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction AT sekiguchijunichiro presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction AT takahashimasao presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction AT kirikaeteruo presenceofantibodiesagainstsarscov2spikeproteininbovinewheyiggenrichedfraction |